Enjoy complimentary customisation on priority with our Enterprise License!
The fertility testing devices market share is expected to increase to USD 153.91 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 5.73%.
This fertility testing devices market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers fertility testing devices market segmentation by product (ovulation predictor kits, fertility monitors, and male fertility testing devices) and geography (North America, Europe, Asia, and Rest of World (ROW)). The fertility testing devices market report also offers information on several market vendors, including Abbott Laboratories, AdvaCare Pharma, Alfa Scientific Designs Inc, Ava AG, Babystart Ltd., bioZhena Corp., Church and Dwight Co. Inc., Geratherm Medical AG, Get Stix Inc., Medical Electronic Systems LLC, Piramal Enterprises Ltd., PREGMATE, Prestige Consumer Healthcare Inc., Quanovate Tech Inc., Quidel Corp., Samplytics Technologies Pvt Ltd., Tempdrop Ltd., The Procter and Gamble Co., UEBE Medical GmbH, and Valley Electronics AG among others.
Download the Free Report Sample to Unlock the Fertility Testing Devices Market Size for the Forecast Period and Other Important Statistics
The rising median age of first-time pregnancies in women is notably driving the fertility testing devices market growth, although factors such as the stringent regulatory bodies may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the fertility testing devices industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Fertility Testing Devices Market Driver
One of the key factors driving growth in the fertility testing devices market is the rising median age of first-time pregnancies in women. In Mexico, the mean age of women at first childbirth was 20-24 years. In Ireland, Italy, South Korea, Spain, and Switzerland, the average age of women at first childbirth was 30-34 years. In Hungary, Latvia, Lithuania, Poland, the Slovak Republic, Turkey, and the US, the average age of women at first childbirth was 25-29 years. Delayed childbearing due to the high prevalence of polycystic ovary syndrome (PCOS), ruptured uterus, amniotic fluid embolism, and delayed parenting are some of the reasons for late pregnancies. Delaying parenthood can cause broad implications on maternal and child health as well as a decline in fertility rates. Thus, the rising median age of first-time pregnancies in women is expected to drive the growth of the global fertility testing devices market.
Key Fertility Testing Devices Market Trend
The easy availability of fertility testing devices on e-commerce sites is a fertility testing devices market trend that is expected to have a positive impact in the coming years. Increasing Internet penetration is leading to a rise in the awareness of online purchase of fertility testing devices. The sales of different products through online channels, including fertility testing devices, are gradually increasing. Vendors are offering various devices, such as fertility testing kits, through e-commerce sites to meet the demand from hospitals, home care settings, and clinics. Fertility testing devices are increasingly sold online through various sites, including Alibaba, Flipkart, Amazon, IndiaMART, and eBay, to consumers in the regions that lack manufacturers, suppliers, and distributors. Vendors are focusing on improving their distribution networks to ensure the availability of products through promotional activities. This trend is set to gain momentum in the market and will eventually support the growth of the market.
Key Fertility Testing Devices Market Challenge
The stringent regulatory bodies will be a major challenge for the fertility testing devices market during the forecast period. Factors such as faulty device designs, malfunction of the devices, and precision and accuracy error rates are some of the issues associated with fertility testing devices, causing misdiagnosis and improper patient management and treatment. Hence, stringent government regulations are imposed on the manufacturing of fertility testing devices. Different regulatory bodies are appointed to guide fertility testing device manufacturers and marketers. Regulatory bodies such as the US Food and Drug Administration (FDA) and the European Union (EU) authorities play a major role in approving these devices and their components. The regulatory requirement in each country with different formalities can strain a company's financial status, especially when it comes to medical devices. Meeting stringent government guidelines can slow down the launch of products in the market, thereby limiting the sales revenue of vendors.
This fertility testing devices market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
Technavio categorizes the global fertility testing devices market as a part of the global healthcare equipment market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the fertility testing devices market during the forecast period.
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
This statistical study of the fertility testing devices market encompasses successful business strategies deployed by the key vendors. The fertility testing devices market is fragmented and the vendors are deploying growth strategies such as introducing innovative products to compete in the market.
abbott.com - The company offers fertility and pregnancy test such as ARCHITECT i1000SR, ARCHITECT c4000 and ARCHITECT c8000.
abbott.com - Under the established pharmaceuticals products segment, the company manufacturers branded generic pharmaceuticals for established and emerging markets.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The fertility testing devices market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Our report provides extensive information on the value chain analysis for the fertility testing devices market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
For more insights on the market share of various regions Request for a FREE sample now!
40% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for fertility testing devices in North America. Market growth in this region will be slower than the growth of the market in the European and Asian regions.
The rising prevalence of PCOS, the increasing age of first-time pregnancy, and the declining fertility rate in the region will facilitate the fertility testing devices market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID Impact and Recovery Analysis
The COVID-19 pandemic in 2020 certainly had a negative impact on the fertility testing devices market in North America Due to manufacturing disruptions for fertility testing devices, which led to supply shortages. However, owing to the successful implementation of large-scale COVID-19 vaccination drives, operations resumed in manufacturing units for fertility testing devices in 2021, leading to a growth in the market in focus; this is expected to continue during the forecast period.
To gain further insights on the market contribution of various segments Request for a FREE sample
The fertility testing devices market share growth by the ovulation predictor kits segment will be significant during the forecast period. The rising median age of first-time pregnancies in women, the increasing preference for ovulation predictor kits due to the convenience they offer, their high efficacy and low-cost benefits, rapid technological advances, and the innovations in the development of such kits are expected to drive the growth of this segment during the forecast period.
This report provides an accurate prediction of the contribution of all the segments to the growth of the fertility testing devices market size and actionable market insights on post COVID-19 impact on each segment.
Infertility Treatment Devices market - The market share is expected to increase by USD 722.40 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 7.75%.
Fertility Testing Devices Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 5.73% |
Market growth 2022-2026 |
$ 153.91 million |
Market structure |
Fragmented |
YoY growth (%) |
5.2 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 40% |
Key consumer countries |
US, Canada, Germany, UK, and China |
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
Key companies profiled |
Abbott Laboratories, AdvaCare Pharma, Alfa Scientific Designs Inc, Ava AG, Babystart Ltd., bioZhena Corp., Church and Dwight Co. Inc., Geratherm Medical AG, Get Stix Inc., Medical Electronic Systems LLC, Piramal Enterprises Ltd., PREGMATE, Prestige Consumer Healthcare Inc., Quanovate Tech Inc., Quidel Corp., Samplytics Technologies Pvt Ltd., Tempdrop Ltd., The Procter and Gamble Co., UEBE Medical GmbH, and Valley Electronics AG |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Product
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.